港股医药高开低走,恒生医药ETF一度涨超1%

Ofweek维科网
Yesterday

美国专利商标局最终裁定Pharmacyclics的803专利全部权利无效,该专利此前被用于指控百济神州的百悦泽侵权。4月30日早盘,百济神州大涨超5%,带动港股医药板块上涨,恒生医药ETF(159892)一度涨超1%,持仓股方舟健客涨超10%,乐普生物、荣昌生物等跟涨。银河证券认为,医药板块经历较长时间调整,整体估值处于较低水平,且公募持仓低配,2025年在支持引导商保发展的政策背景下,支付端有望...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10